A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Condition: Tumors Interventions: Drug: RO7198457; Drug: Atezolizumab Sponsors: Genentech, Inc.; Biontech RNA Pharmaceuticals GmbH Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials